Share on StockTwits

Amsurg Corp (NASDAQ:AMSG) CEO Christopher A. Holden sold 3,000 shares of Amsurg Corp stock on the open market in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $46.39, for a total value of $139,170.00. Following the completion of the transaction, the chief executive officer now directly owns 279,198 shares in the company, valued at approximately $12,951,995. The sale was disclosed in a legal filing with the SEC, which is available at this link.

A number of research firms have recently commented on AMSG. Analysts at Raymond James upgraded shares of Amsurg Corp from a “market perform” rating to a “strong-buy” rating in a research note on Friday, May 30th. They now have a $60.00 price target on the stock. Separately, analysts at Deutsche Bank upgraded shares of Amsurg Corp from a “hold” rating to a “buy” rating in a research note on Thursday, May 29th. They now have a $56.00 price target on the stock, up previously from $47.50. Finally, analysts at Barclays cut their price target on shares of Amsurg Corp from $50.00 to $49.00 in a research note on Thursday, April 24th. They now have an “equal weight” rating on the stock. Four research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $52.17.

Shares of Amsurg Corp (NASDAQ:AMSG) traded up 1.03% during mid-day trading on Wednesday, hitting $48.00. 200,057 shares of the company’s stock traded hands. Amsurg Corp has a one year low of $34.12 and a one year high of $49.84. The stock’s 50-day moving average is $43.44 and its 200-day moving average is $44.68. The company has a market cap of $1.525 billion and a price-to-earnings ratio of 21.12.

Amsurg Corp (NASDAQ:AMSG) last posted its quarterly earnings results on Tuesday, April 22nd. The company reported $0.53 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.55 by $0.02. The company had revenue of $263.11 million for the quarter, compared to the consensus estimate of $272.09 million. During the same quarter last year, the company posted $0.52 earnings per share. Amsurg Corp’s revenue was up 1.9% compared to the same quarter last year. On average, analysts predict that Amsurg Corp will post $2.45 earnings per share for the current fiscal year.

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.